DICE Therapeutics (DICE) Revenue Growth

Price: $47.55
Market Cap: $2.27B
Avg Volume: 1.75M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0
52W Range: $15.08-47.9
Website: DICE Therapeutics

What is DICE Therapeutics's Revenue Growth?

  • DICE Therapeutics's annual revenue growth as of FY 2022 is -100.00%.
  • DICE Therapeutics's quarterly revenue growth as of Q2 2023 is 0.00%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess DICE Therapeutics's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $0
    • Quarterly: $0
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $0
    • Quarterly: $0
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: 0.00%
    • Quarterly Growth: 0.00%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $0
    • Quarterly: $0
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: -100.00%
    • Quarterly Growth: 0.00%

These metrics provide insights into DICE Therapeutics's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

-100.00%

Quarterly Revenue Growth

0.00%

Historical Annual Revenue Growth
69.77%69.77%13.18%13.18%-43.41%-43.41%-100.00%-100.00%Revenue Growth (Annual)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Quarterly Revenue Growth
20.00%20.00%-0.00%-0.00%-20.00%-20.00%-40.00%-40.00%-60.00%-60.00%-80.00%-80.00%-100.00%-100.00%Revenue Growth (Quarterly)Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23
Historical Annual Revenue
$6.00M$6.00M$5.00M$5.00M$4.00M$4.00M$3.00M$3.00M$2.00M$2.00M$1.00M$1.00M$0.00$0.00Revenue (Annual)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Quarterly Revenue
$1.20M$1.20M$900.00K$900.00K$600.00K$600.00K$300.00K$300.00K$0.00$0.00Revenue (Quarterly)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23
Historical Annual Cost of Revenue
$2.00$2.00$1.60$1.60$1.20$1.20$0.80$0.80$0.40$0.40$0.00$0.00Cost of Revenue (Annual)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Quarterly Cost of Revenue
$2.00$2.00$1.60$1.60$1.20$1.20$0.80$0.80$0.40$0.40$0.00$0.00Cost of Revenue (Quarterly)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23
Historical Annual Gross Profit
$6.00M$6.00M$5.00M$5.00M$4.00M$4.00M$3.00M$3.00M$2.00M$2.00M$1.00M$1.00M$0.00$0.00Gross Profit (Annual)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Quarterly Gross Profit
$1.20M$1.20M$900.00K$900.00K$600.00K$600.00K$300.00K$300.00K$0.00$0.00Gross Profit (Quarterly)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23

DICE Therapeutics Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2022 $- -100.00% $- 0.00% $- -100.00%
2021 $1.12M 30.36% $- 0.00% $1.12M 30.36%
2020 $863.00K -85.06% $- 0.00% $863.00K -85.06%
2019 $5.78M 0.00% $- 0.00% $5.78M 0.00%

Related Metrics

Explore detailed financial metrics and analysis for DICE.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio